| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 165.453 | 170.347 | 183.831 | 158.568 | 94.257 | 86.094 | 130.098 | 188.301 | 168.088 | 224.415 |
| Total Income - EUR | 165.453 | 170.347 | 183.831 | 158.572 | 94.257 | 86.094 | 130.105 | 188.304 | 168.088 | 224.416 |
| Total Expenses - EUR | 155.565 | 157.780 | 173.014 | 147.752 | 91.668 | 84.889 | 127.037 | 201.502 | 165.900 | 216.455 |
| Gross Profit/Loss - EUR | 9.889 | 12.567 | 10.817 | 10.820 | 2.589 | 1.205 | 3.068 | -13.198 | 2.188 | 7.961 |
| Net Profit/Loss - EUR | 8.261 | 10.466 | 8.900 | 9.235 | 1.647 | 409 | 1.793 | -15.081 | 541 | 2.466 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Distrimed Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 585 | 277 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 25.227 | 29.188 | 40.567 | 32.727 | 23.780 | 19.734 | 27.703 | 24.929 | 32.497 | 30.462 |
| Inventories | 5.481 | 476 | 6.870 | 2.473 | 488 | 2.628 | 10.772 | 7.173 | 11.706 | 1.607 |
| Receivables | 15.398 | 24.975 | 31.944 | 28.336 | 22.413 | 15.602 | 13.434 | 24.007 | 19.010 | 27.654 |
| Cash | 4.347 | 3.737 | 1.753 | 1.918 | 879 | 1.504 | 3.498 | -6.252 | 1.781 | 1.201 |
| Shareholders Funds | 10.463 | 12.646 | 11.042 | 11.426 | 3.796 | 4.133 | 5.835 | -9.228 | -8.659 | -6.145 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.349 | 16.819 | 29.525 | 21.300 | 19.984 | 15.600 | 21.868 | 34.157 | 41.156 | 36.607 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Distrimed Lab Srl